Generalized epilepsy with febrile seizures plus: novel SCN1A mutation

Area of Science:

• Genetics
• Neurology
• Epilepsy Research

Background:

• Genetic generalized epilepsy with febrile seizures plus (GEFS+) is an idiopathic generalized epilepsy syndrome with diverse clinical presentations.
• Understanding the genetic underpinnings of GEFS+ is crucial for diagnosis and treatment.
• The SCN1A gene is frequently implicated in various epilepsy syndromes.

Observation:

• Two brothers presented with distinct severe epilepsy phenotypes: Dravet syndrome and myoclonic-astatic epilepsy.
• Their father had a history of febrile seizures and generalized tonic-clonic seizures with mild symptoms.
• DNA analysis revealed a novel SCN1A gene mutation (c.3925 C>T) in exon 20 in both affected siblings, but not in their mother.

Findings:

• A previously unreported missense mutation in the SCN1A gene was identified in the affected siblings.
• This mutation was presumed to be inherited from their father, who exhibited a much milder phenotype.
• The study highlights significant intrafamilial variability in the clinical expression of SCN1A gene mutations.

Implications:

• This finding expands the known spectrum of SCN1A mutations associated with GEFS+.
• It underscores the importance of considering parental history, even if mild, in diagnosing genetic epilepsy syndromes.
• The intrafamilial variability observed has implications for genetic counseling and understanding genotype-phenotype correlations in epilepsy.